KabaFusion Partners with Tennr to Enhance Patient Outcomes in Home Infusion Care with AI Technology

Strategic Partnership Uses AI to Advance Patient Care, Empower Clinicians, and Optimize Home Infusion Services

NEW YORK, Sept. 10, 2025 /PRNewswire/ -- KabaFusion, a nationally recognized leader in home infusion, and Tennr, a healthcare technology company that automates patient processing for referral-based care, today announced a strategic partnership to further streamline care coordination, drive operational efficiencies, and improve patient outcomes through the use of artificial intelligence (AI).

"Our North star has always been to reduce patient care delays across the US," said Trey Holterman, CEO at Tennr. "It's always refreshing when a partner as well-known as KabaFusion is aligned on the goal of delivering the fastest patient care possible and preventing patients from slipping through the cracks."

This collaboration will use Tennr's advanced automation and data-driven insights to strengthen KabaFusion's referral management processes, eliminating delays in patient onboarding and enhancing the patient experience. This approach will enable KabaFusion's clinicians to devote more time to direct patient care and less time navigating administrative bottlenecks that delay treatment, ensuring that patients receive timely, consistent, high-quality care across KabaFusion's rapidly growing national network of home infusion pharmacies, alternative infusion sites, and home health agencies.

"At KabaFusion, clinical excellence and human compassion have always been at the heart of our operations," said Tina Benkendorfer, PharmD, Chief Operating Officer & Chief Compliance Officer, KabaFusion. "By integrating Tennr's advanced technology, we are reducing the administrative burden on our clinical teams and enhancing our ability to deliver timely, high-quality care so that our clinicians can focus on what matters most—the health and wellbeing of our patients."

This partnership with Tennr underscores KabaFusion's position as an industry leader that not only adapts to change but drives it, embracing innovations in healthcare technology solutions without compromising the compassionate care that has defined its legacy.

About Tennr: Tennr is a healthcare technology company dedicated to eliminating patient delays throughout the U.S. healthcare system. Founded by Stanford classmates, Tennr has raised over $160M from investors including IVP, Andreessen Horowitz (a16z), and Lightspeed Venture Partners. The company's referral automation platform accelerates patient throughput, helping healthcare providers capture more referrals and reduce denials without growing their teams.

About KabaFusion: KabaFusion is a national provider of essential chronic and acute infusion therapies. The company serves patients in 45 states through its nationwide network of home infusion pharmacies, alternative infusion sites, and home health agencies. KabaFusion was founded in 2010 by Chief Executive Officer Dr. Sohail Masood, a pioneer in patient focused infusion therapies with more than 30 years of clinical experience. The company is dedicated to working proactively with patients, healthcare practitioners, and payors to provide comprehensive support before, during and after treatment. For more information, visit www.kabafusion.com. 

SOURCE Tennr